News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Biller Jonathan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Biller Jonathan (EVP and Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 408 shares
@ $350.72, valued at
$143.1k
Sold 610 shares
@ $346.76, valued at
$211.5k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2022 |
4
| Biller Jonathan (EVP and Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 5,294 shares
@ $0 |
|
| 09/21/2022 |
3
| Biller Jonathan (EVP and Chief Legal Officer) has filed a Form 3 on VERTEX PHARMACEUTICALS INC / MA |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Biller Jonathan (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,349 shares
@ $31.425, valued at
$42.4k
Exercised 3,667 restricted stock units
@ $0 |
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Biller Jonathan (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,707 shares
@ $45.87, valued at
$78.3k
Exercised 5,753 restricted stock units
@ $0 |
|
| 04/15/2020 |
4
| Biller Jonathan (Chief Legal Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,529 shares
@ $40.64, valued at
$102.8k
Exercised 8,523 options to buy
@ $0 |
|
| 12/05/2019 |
4
| Biller Jonathan (Chief Legal Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 78,824 options to buy
@ $39.11, valued at
$3.1M
Granted 17,259 restricted stock units
@ $0 |
|
| 12/05/2019 |
3
| Biller Jonathan (Chief Legal Officer) has filed a Form 3 on AGIOS PHARMACEUTICALS, INC. |
| 11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2019 |
4
| Biller Jonathan (EVP AND GENERAL COUNSEL) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Paid exercise price by delivering 490 shares
@ $95.21, valued at
$46.7k
Exercised 1,563 restricted stock units
@ $0 |
|
| 03/05/2019 |
4
| Biller Jonathan (EVP AND GENERAL COUNSEL) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 31,714 restricted stock units
@ $0 |
|
| 12/18/2018 |
4
| Biller Jonathan (EVP AND GENERAL COUNSEL) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Paid exercise price by delivering 935 shares
@ $68.2, valued at
$63.8k
Exercised 1,900 restricted stock units
@ $0 |
|
| 08/07/2018 |
3/A
| Biller Jonathan (EVP and General Counsel) has filed a Form 3/A on CELGENE CORP /DE/ |
| 07/12/2018 |
3
| Biller Jonathan (EVP and General Counsel) has filed a Form 3 on CELGENE CORP /DE/ |
|
|